Comparative evaluation of the acute toxic effects in monkeys, pigs and mice of a genetically engineered Salmonella strain (VNP20009) being developed as an antitumor agent

International Journal of Toxicology

Volumn 19, Issue 1, 2000, Pages 19-25

  Lee, King C ^a   Zheng, Li Mou ^a   Luo, Xiang ^a   Clairmont, Caroline ^a   Fischer, Jessica ^a   Margitich, Dennis ^b   Turnier, John ^c   Almassian, Bijan ^a   Bermudes, David ^a   King, Ivan ^a  

^a Vion Pharmaceuticals Incorporated   (United States)

^b Oread Biosafety   (United States)

^c Pathology Associates International   (United States)

Author keywords

Attenuation; Genetically Engineered Salmonella Strain; VNP20009

Indexed keywords

ANTINEOPLASTIC AGENT; LIVER ENZYME; UNCLASSIFIED DRUG; VNP 20009;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LETHAL DOSE; LUNG; MALE; MESENTERY LYMPH NODE; MONKEY; MORTALITY; MOUSE; NONHUMAN; SALMONELLA; SPLEEN; SWINE; THYMUS; VIRULENCE;

ANIMALIA; MACACA FASCICULARIS; SALMONELLA; SALMONELLA TYPHIMURIUM; SUS SCROFA; TYPHIMURIUM;

EID: 12944335180     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158100225006     Document Type: Article

References (17)

1. Bone, R. C. 1992. Editorial comments in attenuating the effects of endotoxin. J Lab. Clin. Med. 119:323-324.
2. Carpati, C. M., M. E. Astiz, E. C. Rackow, J. W. Kim, Y. B. Kim, and M. H. Weil. 1992. Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab. Clin. Med. 119:346-353.
3. Carrier, M. J., S. N. Chatfield, G. Dougan, U. T. A. Nowicka, D. O'Callaghan, J. E. Beesley, S. Milano, E. Cillari, and F. Y. Liew. 1992. Expression of human IL-Ib in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo. J Immunol. 148:1176-1181.
4. Chen, L. M., K. Kaniga, and J. E. Galan. 1996. Salmonella spp. are cytotoxic for cultured macrophages. Mol Microbio. 21:1101-1115.
5. Eisenstein, T. K., B. Bushnell, J. J. Meissler, Jr., N. Dalal, R. Schafer, and H. F. Havas. 1995. Immunotherapy of a plasmacytoma with attenuated Salmonella. Med. Oncol. 12:103-108.
6. Flad, H. D., H. Loppnow, E. T. Rietschel, and A. J. Ulmer. 1993. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187:303-316.
7. Karow, M., and C. Georgopolous. 1992. Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. J. Bacteriol. 174:702-710.
8. A inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J. Exp. Med. 172: 77-84.
9. Li, J. X., J. R. Oliver, C. Y. Lu, K. D. Grantham, and J. B. Philips, III. 1993. Age-related differences in responses to endotoxin infusion in unanesthetized piglets. Circ Shock 41:40-47.
10. Low, K. B., M. Ittensohn, T. Le, J. Platt, S. Sodi, M. Amoss, O. Ash, E. Carmichael, A. Chakraborty, J. Fischer, S. L. Lin, X. Luo, S. I. Miller, L-M. Zheng, I. King, J. M. Pawelek, and D. Bermudes. 1999a. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumortargeting in vivo. Nature Biotech. 17:37-41.
11. Low, K. B., M. Ittensohn, S. Lin, C. Clairmont, X. Luo, L.-M. Zheng, I. King, J. M. Pawelek, and D. Bermudes. 1999b. VNP20009, a genetically modified Salmonella typhimurium for treatment of solid tumors. Proc. Am. Assoc. Can. Res. 40:87. (Abstract 581)
12. Pawelek, J. M., K. B. Low, and D. Bermudes. 1997. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57:4537-4544.
13. Rocha, G., J. Deschenes, and J. J. Rowsey. 1998. The immunology of corneal graft rejection. Crit. Rev: Immunol. 18:305-325.
14. Saltzman, D. A., C. P. Heise, D. E. Hasz, M. Zebede, S. M. Kelly, R. Curtiss, A. S. Leonard, and P. M. Anderson. 1996. Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent. Cancer Biother. Radiopharm. 11:145-153.
15. Saltzman, D. A., E. Katsanis, C. P. Heise, D. E. Hasz, S. M. Kelly, R. Curtiss, III, A, S. Leonard, and P. M. Anderson. 1997. Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: A novel anti-tumor agent. Cancer Biother. Radiopharm. 12:37-45.
16. Siebeck, M., J. Kohl, S. Endres, M. Spannagl, and W. Machleidt. 1994. Delayed treatment with platelet activating factor receptor antagonist WEB 2086 attenuates pulmonary dysfunction in porcine endotoxin shock. J. Trauma. 37:745-751.
17. Zheng L. M., X. Luo, J. Fischer, T. Le, D. Bermudes, B. Low. J. Pawelek, and I. King. 1997. Attenuated Salmonella typhimurium inhibited tumor metastasis in vivo. Proc. Am. Assoc. Can. Res. 38:9. (Abstract.)